Philadelphia, PA (PRWEB) June 29, 2017
Pentec Health, Inc., a leader in personalized sterile compounding and manufacturing, shares that Dr. Michael M. Crow, President of Arizona State University, announced that the university has acted favorably on the nomination of Joseph Cosgrove to the Trustees of ASU. Mr. Cosgrove’s appointment to the Board was formally announced at a meeting held in New York on June 5, 2017. He will also be the Board’s “Ambassador/Liaison” to Sun Devil Athletics. The prestigious advisory board was established by Dr. Crow in 2013 as part of his master plan to further reinforce ASU’s position as a global leader among academic institutions. Drawing on the experience and expertise of its members the Board strives to influence ASU positively and in keeping with Dr. Crow’s vision of the “New American University.”
The Trustees of ASU is comprised of a distinguished and diverse representation of leaders in various academic, professional and business disciplines. Board trustees offer the University a unique perspective on relevant academic, administrative, philanthropic and management issues gleaned from their experiential skill sets. Dr. Crow publically endorsed Joe Cosgrove and lauded him as a successful leader in the healthcare industry, demonstrating innovative and entrepreneurial traits, and as an ardent supporter of ASU’s mission and vision.
Mr. Cosgrove acknowledged the appointment stating his appreciation and continued support and dedication to ASU’s short and long term goals and ideals. He stated, “In my business career I have learned the value of courageously challenging the status quo, of fostering innovation and of encouraging an entrepreneurial spirit. The need for agility and adaptability is also essential. Clearly, there are direct parallels with Dr. Crow’s strategic objectives; it is this personal portfolio and commitment that I hope to bring to the Board.”
As Chairman, President and CEO of Pentec Health Inc. Mr. Cosgrove has shepherded the firm through unprecedented periods of expansion, diversification of services and profitability. In addition to his role as Chairman of the Board of Directors for Pentec Health, Mr. Cosgrove also serves as a board member for the National Kidney Foundation. Mr. Cosgrove’s ASU board appointment is effective as of July 1.
About Pentec Health
For over 30 years, Pentec Health has been an industry leader in providing patient-specific compounded sterile medications. Pentec Health’s medications are used for administration in dialysis centers, as well as providing in-home Specialty Infusion through nursing services and complex pharmaceutical products to patients who require access outside of a hospital setting. Pentec Health is also registered with the Food and Drug Administration as an outsourcing facility, providing sterile compounds to meet the needs of the nation’s institutional healthcare segments. For more information, please visit http://www.pentechealth.com.
About Arizona State University
Arizona State University, which for two years has been designated by U.S. News and World Report as the most innovative university in the country, has a world class Entrepreneurship and Innovation program embedded in the university. The University has developed a new model for the American Research University, creating an institution that is committed to access, excellence and impact. ASU measures itself by those it includes, not by those it excludes. As the prototype for a New American University, ASU pursues research that contributes to the public good and assumes major responsibility for the economic, social and cultural vitality of the communities that surround it.
Pentec Health, Inc.